You just read:

First Study Initiated to Evaluate the Effect of Ofev® Treatment on Biomarkers that may Predict IPF Progression

News provided by

Boehringer Ingelheim Pharmaceuticals, Inc.

Jul 27, 2016, 08:00 ET